Provectus Biopharmaceuticals Inc (PVCT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Provectus Biopharmaceuticals Inc (PVCT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3345
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], pediatric solid tumors and other tumors. It is developing a new class of drugs based on halogenated xanthenes such as Rose Bengal. Provectus offers PH-10 for psoriasis and atopic dermatitis. The company conducts research on ongoing clinical trials for indications including breast cancers, melanoma, head and neck cancers, basal cell carcinoma and squamous cell carcinoma. It operates through its offices in Tennessee and New York, the US. Provectus is headquartered in Knoxville, Tennessee, the US.

Provectus Biopharmaceuticals Inc (PVCT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Provectus Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Provectus Biopharma Enters into Research Agreement with POETIC 11
Licensing Agreements 12
Provectus to Enter into Licensing Agreement with Sinopharm-CSIPI and Sinopharm A-THINK for PV-10 12
Equity Offering 14
Provectus Biopharma Raises USD6 Million in Public Offering of Series B Preferred Stock and Warrants 14
Provectus Biopharma Raises USD0.8 Million in Private Placement of Shares 16
Provectus Biopharma Raises USD1 Million in Private Placement of Shares 17
Provectus Biopharma Raises USD13.1 Million in Public Offering of Shares and Warrants 18
Provectus Biopharma Raises USD5 Million in Private Placement of Shares 20
Provectus Biopharma Raises USD3.6 Million in Private Placement of Shares 21
Provectus Biopharma Raises USD4.2 Million in Private Placement of Shares 22
Provectus Pharma Announces Private Placement Of Shares For Up To US$30 Million 23
Provectus Pharma Completes Private Placement Of Units For US$2 Million 24
Provectus Pharma Completes Private Placement Of Units For US$2.1 Million 25
Provectus Biopharmaceuticals Inc – Key Competitors 26
Provectus Biopharmaceuticals Inc – Key Employees 27
Provectus Biopharmaceuticals Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Corporate Communications 29
Apr 20, 2017: Provectus Biopharmaceuticals Reestablishes Strategic Advisory Board 29
Feb 23, 2017: Provectus Biopharmaceuticals Appoints Bruce Horowitz And Dominic Rodrigues As Special Advisers To The Board Of Directors 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Provectus Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Provectus Biopharma Enters into Research Agreement with POETIC 11
Provectus to Enter into Licensing Agreement with Sinopharm-CSIPI and Sinopharm A-THINK for PV-10 12
Provectus Biopharma Raises USD6 Million in Public Offering of Series B Preferred Stock and Warrants 14
Provectus Biopharma Raises USD0.8 Million in Private Placement of Shares 16
Provectus Biopharma Raises USD1 Million in Private Placement of Shares 17
Provectus Biopharma Raises USD13.1 Million in Public Offering of Shares and Warrants 18
Provectus Biopharma Raises USD5 Million in Private Placement of Shares 20
Provectus Biopharma Raises USD3.6 Million in Private Placement of Shares 21
Provectus Biopharma Raises USD4.2 Million in Private Placement of Shares 22
Provectus Pharma Announces Private Placement Of Shares For Up To US$30 Million 23
Provectus Pharma Completes Private Placement Of Units For US$2 Million 24
Provectus Pharma Completes Private Placement Of Units For US$2.1 Million 25
Provectus Biopharmaceuticals Inc, Key Competitors 26
Provectus Biopharmaceuticals Inc, Key Employees 27
Provectus Biopharmaceuticals Inc, Subsidiaries 28

List of Figures
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Provectus Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Provectus Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Provectus Biopharmaceuticals Inc (PVCT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Steelcase Inc.:企業の戦略・SWOT・財務情報
    Steelcase Inc. - Strategy, SWOT and Corporate Finance Report Summary Steelcase Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • University of Maryland Medical Center Corp:企業の戦略的SWOT分析
    University of Maryland Medical Center Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Kao Corporation:企業の戦略・SWOT・財務情報
    Kao Corporation - Strategy, SWOT and Corporate Finance Report Summary Kao Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • ObsEva SA (OBSV):企業の財務・戦略的SWOT分析
    ObsEva SA (OBSV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MEG Energy Corp (MEG):石油・ガス:M&Aディール及び事業提携情報
    Summary MEG Energy Corp (MEG) is an oil and gas company that develops and produces from oil sands. The company operates Christina lake, May River and Surmont project. Its technologies comprise steam-assisted gravity drainage, cogeneration, Hi-Q field pilot and eMSAGP. MEG's Christina Lake project is …
  • FactSet Research Systems Inc. (FDS):企業の財務・戦略的SWOT分析
    FactSet Research Systems Inc. (FDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Territorial Generating Company #2 (TGKB)-エネルギー分野:企業M&A・提携分析
    Summary Territorial Generating Company #2 (TGC-2) is a power generating company. The company produces and transmits electricity, as well as heat, such as steam and hot water. TGC-2 through its subsidiaries offers its products and services to customers located in Arkhangelsk, Vologda, Kostroma, Novgo …
  • Kilitch Drugs India Ltd (KILITCH):製薬・医療:M&Aディール及び事業提携情報
    Summary Kilitch Drugs India Ltd (Kilitch) is a pharmaceutical company that manufactures and markets antibacterial parenteral formulations and other pharmaceutical products. The company offers products such as parenterals and nasal products, oral, effervesscent, nutritional products, medical device, …
  • Ginza Project:企業の戦略・SWOT・財務情報
    Ginza Project - Strategy, SWOT and Corporate Finance Report Summary Ginza Project - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sea Run Holdings Inc:製品パイプライン分析
    Summary Sea Run Holdings Inc (Sea Run Holdings) is a healthcare solutions provider that discovers and develops innovative reagents and therapeutics. The company’s pipeline products include salmon plasma and salmon fibrin products. Its salmon plasma product provides effective treatment for acute pain …
  • AGC Inc (5201):企業の財務・戦略的SWOT分析
    AGC Inc (5201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Corgenix Medical Corp-医療機器分野:企業M&A・提携分析
    Summary Corgenix Medical Corp (Corgenix), a subsidiary of Orgentec Diagnostika GmbH is a medical device company that offers medical diagnostic solutions. The company offers vascular disease products, infectious disease products, non-invasive liver biomarkers, and instrumentation. It offers an instru …
  • Genera Biosystems Ltd (GBI):製品パイプライン分析
    Summary Genera Biosystems Ltd (GBL) is a developer and commercializer of multiplexed molecular diagnostic testing products. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pat …
  • The Providence Service Corporation:企業の戦略・SWOT・財務情報
    The Providence Service Corporation - Strategy, SWOT and Corporate Finance Report Summary The Providence Service Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Biotest AG (BIO):企業の財務・戦略的SWOT分析
    Biotest AG (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Curetis NV (CURE)-医療機器分野:企業M&A・提携分析
    Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company offers diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for variety of cartridges, diseases such as pneumonia, im …
  • Baloise Holding Ltd (BALN):企業の財務・戦略的SWOT分析
    Baloise Holding Ltd (BALN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Eagle Plains Resources Ltd (EPL):企業の財務・戦略的SWOT分析
    Summary Eagle Plains Resources Ltd (Eagle Plains) operates as a mining and mineral exploration and mine development company that offers mineral resources. The company offers acquisition, exploration, mining, operations, management, production, and development gold, base metals, rare earth elements, …
  • Buffalo Rock Company:企業の戦略・SWOT・財務情報
    Buffalo Rock Company - Strategy, SWOT and Corporate Finance Report Summary Buffalo Rock Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • KSK Group Berhad:企業の戦略・SWOT・財務情報
    KSK Group Berhad - Strategy, SWOT and Corporate Finance Report Summary KSK Group Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆